New Delhi [India], June 4 (ANI): The Punjab government on Friday withdrew its earlier order of providing "one-time" limited vaccine doses to the 18-44 age group population through private hospitals after allegations by opposition of "diverting" Covaxin doses at "hefty margins", sparked a row
New Delhi [India], June 4 (ANI): Centre through an affidavit on Friday informed the Delhi High Court that on May 12, 2021, the Drug Controller General of India (DCGI) has permitted Bharat Biotech to conduct clinical trials on healthy volunteers between 2 years to 18 years of age for its vacc
Meerut (Uttar Pradesh) [India], June 4 (ANI): People living in Delhi and Haryana are now booking slots to get their second dose of Covid-19 in Meerut, according to district immunisation Officer Praveen Gautam.
Washington [US], June 4 (ANI): Since March, over 400 US colleges and universities have announced students get Covid-19 vaccinations, ahead of the Autumn semester but those who have been inoculated with India's indigenous Covaxin or the Russian-made Sputnik V are being asked to re-vaccinate a
Washington [US], June 4 (ANI): US National Security Advisor Jake Sullivan on Thursday (local time) discussed the sharing of 25 million COVID-19 vaccines with the world and said that the US will not use it to secure favours from other countries in lieu of the pandemic assistance.
Hyderabad (Telangana) [India], June 3 (ANI): Hyderabad-based Bharat Biotech on Thursday said that biopharmaceutical company Ocugen Inc will have exclusive co-development, manufacturing, and commercialisation rights of its COVID-19 vaccine Covaxin in Canada, in addition to its existing Uni
New Delhi [India], June 3 (ANI): After All India Institute of Medical Sciences (AIIMS), Patna, now AIIMS Delhi is also planning to start the Paediatric clinical trials of the indigenous Bharat Biotech's COVID-19 vaccine "Covaxin" in few days, sources said on Thursday.
New Delhi [India], June 3 (ANI): A Fresh application was moved in Delhi High Court on Thursday seeking to stay the operation of the order of Drugs Controller General of India (DCGI) for conducting phase II/III clinical trials of Whole Virion Inactivated Coronavirus Vaccine in the 2 to 18 yea
Patna (Bihar) [India], June 3 (ANI): Patna's All India Institute of Medical Sciences (AIIMS) has started the paediatric trials for the COVID-19 vaccine manufactured by the Bharat Biotech, Covaxin.
Tokyo [Japan], June 3 (ANI): Japanese Prime Minister Yoshihide Suga on Wednesday pledged an additional USD 800 million to COVAX facility aiming for a fair distribution of coronavirus vaccines worldwide.
New Delhi [India], June 2 (ANI): The Supreme Court on Wednesday directed the Central government to submit complete data on its purchase history along with administration of doses of all the COVID-19 vaccines-- Covaxin, Covishield and Sputnik V-- till date.
Mumbai (Maharashtra) [India], June 2 (ANI): Haffkine Bio-Pharmaceutical Corporation Limited (HBPCL), a Maharashtra government undertaking, is preparing for mass production of Covaxin and will have capacity to produce over 22 crore doses of the COVID-19 vaccine every year once the requisit